Priothera to Present Trial in Progress Poster for Mocravimod at 2024 American Society of Hematology (ASH) Annual Meeting
03 déc. 2024 06h00 HE
|
Priothera
Mocravimod is being investigated in a global MO-TRANS Phase 3 study in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation Mocravimod is the only S1P receptor...
Innovate BC Awards $1.5M to Five Research & Development Projects Advancing Clean Tech and Life Sciences Solutions in British Columbia
28 nov. 2024 17h48 HE
|
Innovate BC
Through its Ignite program, Innovate BC has awarded $1.5M across 5 B.C.-based R&D projects developing solutions that address priority challenges.
Avextra Portugal Unveils Advanced Breeding Program to Develop Proprietary THC and CBD Cultivars, Establishing a Key IP Pillar
20 nov. 2024 07h00 HE
|
Avextra AG
Avextra Portugal launches an innovative in-house breeding program to develop proprietary cannabis varieties with specific, consistent and reproducible cannabinoid and terpene profiles.Over a two-year...
Kneat Achieves Record Results in Growth and Profitability
06 nov. 2024 17h04 HE
|
kneat.com, inc.
Kneat achieves record results in growth and profitability, as third-quarter 2024 revenue and gross profit growth accelerate to 52% and 78% respectively,
Global Medical Devices Manufacturer Selects Kneat to Digitize Validation
31 oct. 2024 17h13 HE
|
kneat.com, inc.
Kneat signs a global and diverse medical devices manufacturer for digital validation.
Kneat to Announce 2024 Third-Quarter Financial Results November 6, 2024
30 oct. 2024 17h17 HE
|
kneat.com, inc.
Kneat to Announce 2024 Third-Quarter Financial Results November 6, 2024, and Host an Earnings Call on November 7
ProductLife Group (PLG) Acquires Callisto to Strengthen Regulatory Services in the UK and EU
30 oct. 2024 04h00 HE
|
ProductLife Group (PLG)
ProductLife Group is excited to announce the acquisition of Callisto, a leading UK-based consultancy
INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Edwards Lifesciences Corporation (NYSE: EW); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel
23 oct. 2024 17h21 HE
|
DiCello Levitt LLP
SAN DIEGO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired Edwards Life Sciences Corporation. (NYSE:...
The Riverside Company Cell-ebrates with Sale of Red Nucleus
17 oct. 2024 13h00 HE
|
The Riverside Company
CLEVELAND, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The Riverside Company (Riverside), a global investment firm focused on the smaller end of the middle market, has sold its investment in Red Nucleus, a...
ProductLife Group (PLG) Acquires Halloran to Further Expand Its Global Reach and Capabilities to Support the Development of New Therapies
17 oct. 2024 08h00 HE
|
ProductLife Group (PLG)
ProductLife Group (PLG) today announced the acquisition of Halloran Consulting Group, a life science consulting firm.